Creatine Kinase Isoenzyme Detection Reagent(CK-MB) (Immunofluorescence Chromatography) Clinical comparison

CK-MB Overview

Creatine kinase enzyme (CK-MB) is an enzyme system widely found in human striated muscle. When the transverse muscle, such as myocardium and skeletal muscle, is damaged, the creatine kinase isoenzyme is released into the blood and begins to rise after 4-6 hours, with a peak time of 24 hours and a recovery time of 48-72 hours.

CK-MB performance index

CK-MB Clinical significance

• AMI is diagnosed early and stratified at risk.
• Estimate infarct size or reinfarct size
• The most valuable markup of MI is the non-ST increment.

CK-MB Clinical value

The isotinase of sarcosine kinase plays an important role in clinical diagnosis. Serum levels of creatine kinase in humans increase rapidly in response to various diseases, such as muscle dystrophy and myocardial infarction. The activity of sarcosine kinase can detect the diagnosis of myocardial infarction more accurately than ECG. In myocardial infarction, sarcosine kinase increases within 6 hours of onset, peaks at 24 hours, and returns to normal within 3-4 days. The creatine kinase isoenzyme CK-MB has the highest diagnostic specificity. Because of its important physiological function and clinical value, sarcosine kinase has been studied extensively and deeply.

CK-MB Normal value

1. Electrophoretic method: CK-MB<0.05 (CK-MB<5%) CK-MM>0.94 ~ 0.96 (CK-MM>94% ~ 96%) CK-BB no or trace (CK-BB no or trace)
2. Enzyme rate method (37℃) CK-MB: 0 ~ 18U/L CK-MM: 0 ~ 18U/L CK-BB: 0U/L.

Application Department

Cardiology, emergency, laboratory, pediatrics, hematology, oncology, Nephrology, surgery, etc

CK-MB Clinical comparison

MYO Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.